Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.

MLA

Gordon, Stephen B., et al. “Inhaled Delivery of 23-Valent Pneumococcal Polysaccharide Vaccine Does Not Result in Enhanced Pulmonary Mucosal Immunoglobulin Responses.” Vaccine, vol. 26, no. 42, Oct. 2008, pp. 5400–06. EBSCOhost, https://doi.org/10.1016/j.vaccine.2008.07.082.

APA

Gordon, S. B., Malamba, R., Mthunthama, N., Jarman, E. R., Jambo, K., Jere, K., Zijlstra, E. E., Molyneux, M. E., Dennis, J., & French, N. (2008). Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses. Vaccine, 26(42), 5400–5406. https://doi.org/10.1016/j.vaccine.2008.07.082

Chicago

Gordon, Stephen B, Rose Malamba, Neema Mthunthama, Elizabeth R Jarman, Kondwani Jambo, Khuzwayo Jere, Eduard E Zijlstra, Malcolm E Molyneux, John Dennis, and Neil French. 2008. “Inhaled Delivery of 23-Valent Pneumococcal Polysaccharide Vaccine Does Not Result in Enhanced Pulmonary Mucosal Immunoglobulin Responses.” Vaccine 26 (42): 5400–5406. doi:10.1016/j.vaccine.2008.07.082.